000739:SHE
Apeloa Pharmaceutical Co Ltd
24,59 CNY
arrow_downward
-0,69%(-0,17) 1d
14 d’oct., 15:04:42 GMT+8 · CNY
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 000739...
Obre
24,47 CNY
Alt
25,24 CNY
Baix
24,40 CNY
Capitalització borsària
28,68 kM
Volum mitjà
17,13 M
Volum
10,27 M
Dividend
1,53 %
Dividend trimestral
0,09 CNY
Data de l'exdividend
8 d’oct. 2026
Ràtio preu-benefici
33,37
Alt 52 setmanes
28,50 CNY
Baix 52 setmanes
14,89 CNY
BPA
0,74 CNY
Accions en circulació
1158,44 M
Nombre d'empleats
7 k
Obre
24,47 CNY
Alt
25,24 CNY
Baix
24,40 CNY
Capitalització borsària
28,68 kM
Volum mitjà
17,13 M
Volum
10,27 M
Dividend
1,53 %
Dividend trimestral
0,09 CNY
Data de l'exdividend
8 d’oct. 2026
Ràtio preu-benefici
33,37
Alt 52 setmanes
28,50 CNY
Baix 52 setmanes
14,89 CNY
BPA
0,74 CNY
Accions en circulació
1158,44 M
Nombre d'empleats
7 k
Notícies
De fonts web i partners de notícies
Stocktwits
·
fa 16 minuts
S&P 500, Nasdaq See Worst Day In Over Two Months As Chipmaker Rout Deepens, CPI Data Comes In Hot — AAPL, SPCX, DRAM, SOXX In Focus
Yahoo Finance
·
fa 40 minuts
Invesco QQQ Doesn't Own a Single Bank, and That's Not the Only Thing the Nasdaq-100 Leaves Out
Simply Wall Street
·
fa 35 minuts
Lumentum Is Up 472% Even As It Swung To A Loss
Bloomberg.com
·
fa 3 hores
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Perfil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Sobre Apeloa Pharmaceutical Co Ltd